GlassScriptPhysician profile
Dana Garnand
NPI 1649684267
$1,670.12
in general payments reported to CMS, 2019-2025
15 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $153 · 2022: $831 · 2023: $416 · 2024: $77.71 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534 · Travel and Lodging: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.28 |
| Travel and Lodging | $151.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $620.22 | 2022-2024 | Axonics |
| Medtronic, INC. | $254.86 | 2023 | Interstim |
| Coloplast Corp | $123.03 | 2021-2025 | |
| C. R. Bard, INC. & Subsidiaries | $114.68 | 2023 | Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $108.02 | 2023-2025 | Gemtesa, Orgovyx |
| Myovant Sciences INC. | $79.13 | 2022 | |
| Astellas Pharma US INC | $67.76 | 2022-2023 | Myrbetriq |
| Gilead Sciences, INC. | $63.54 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $60.29 | 2022 | |
| Urovant Sciences INC | $49.19 | 2022 | |
| Olympus America INC. | $39.31 | 2025 | Itind System |
| Tolmar, INC. | $27.57 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.52 | 2025 | |
| Endo USA, INC. | $22.45 | 2025 | Xiaflex |
| Boston Scientific Corporation | $16.55 | 2025 | Spaceoar Vue System - 10ml |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Garnand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.